Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
1.1%
1w
0.3%
1m
4.6%
3m
12.5%
6m
13.5%
1y
38.1%
all
24.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,012 1.1%
786
1,082
Company Overview

Sales
2,170 Cr
Growth: 29.1%
Profit after Tax
333 Cr
Growth: 16.2%
Mid Cap
21,441 Cr
P/E: 64.9x
Industry P/E: 27.1x
Fundamentals

Sales (Cr) ₹ 2,170
Growth 29.1%
EBITDA 28.2%
P/S 9.9x
Dividend 0.0%
P/E 64.9x
Book Value ₹ 112
PEG Ratio 2.2x
ROE 14.9%
P/B 9.0x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Followers (1)